PEP-Therapy Competitors and Similar CompaniesClear all
PEP-Therapy's competitors and similar companies include Harpoon Therapeutics and ISA Pharmaceuticals.
 PEP-Therapy PEP-Therapy is a medical biotechnology company, that develops peptides as targeted therapies for severe diseases, with an initial focus on cancer. | |||
Founding Date | Founding Date 2014 | Founding Date 2015 | Founding Date 2004 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Paris, FR HQ Évry, FR | Locations South San Francisco, US HQ Louisville, US South San Francisco, US | Locations HQ |
Employees | Employees 14 | Employees 45 | Employees 517% decrease |
Funding | |||
Latest funding round | Latest funding round $ 3m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 30.8m (about 5 years ago) |
Total funding raised | Total funding raised $ 3m | Total funding raised $ 130m | Total funding raised $ 41.2m |
For sources of this data, please see the company profile
View Company Profiles
Harpoon Therapeutics
HQ
South San Francisco, US
Employees
45
Harpoon Therapeutics is a preclinical stage biotechnology company.
View company
ISA Pharmaceuticals
HQ
Employees
5↓ 17% decrease
ISA Pharmaceuticals is an immunotherapy company.
View company